Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Exec appointment
confidence 92%
filed 2026-08-10
The 6-K announces the nomination of Ms. Janet DiFiore to the Board of Directors to fill the seat vacated by Mr. Gurpal Grewal, who determined not to stand for re-election. Although the appointment is subject to shareholder approval at the upcoming annual meeting, the principal disclosed action is the nomination of a director candidate with substantial public-sector credentials (former Chief Judge of New York Court of Appeals). This is a material governance event affecting board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 5.02
Dr. Charles S. Fuchs was appointed President, Research & Development of Erasca, Inc., effective August 10, 2026. This is a material executive appointment of a senior officer with significant oncology and biopharmaceutical development experience, including prior roles at Roche/Genentech and Yale Cancer Center. The appointment includes substantial compensation (base salary $570,000, 45% bonus target, and 1.3 million stock options), making it material to investors' assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
Item 5.02
The filing discloses the appointment of Eric Williams as Executive Vice President of Engineering, effective August 31, 2026. While the disclosure also includes compensatory arrangements (base salary of $400,000 and 40% target bonus), the principal action is the appointment of a named executive officer with significant prior experience (three decades of advanced reactor engineering leadership from TerraPower). The appointment of a senior executive to a newly-filled or newly-created role is material to investors assessing the company's leadership and operational capacity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
The filing discloses the appointment of Kenji Konishi as Head of Magnet Engineering Production, a senior operational leadership role. The press release emphasizes his decades of experience scaling rare earth magnet production and notes he is joining with "a team of senior engineers," positioning this as a material executive appointment critical to the company's expansion toward 10,000 metric tons of annual capacity by November 2026 and DFARS compliance by January 1, 2027.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-10
The 6-K announces the appointment of Daniel Brau as Chief Quantum Officer of SEALSQ effective August 4, 2026, following the Company's acquisition of Miraex SA. The disclosure includes detailed biographical information, his prior role as CEO of the acquired company, and his new responsibilities overseeing the quantum technology portfolio and strategic partnerships. This is a material executive appointment tied to a significant acquisition integration.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-10
EX-99.1
The press release announces the appointment of André Cazotto as Chief Financial Officer of PicPay, effective immediately, succeeding Rodrigo Couto who transitions to Special Advisor. This is a material executive appointment at the C-suite level (CFO) at a recently IPO'd company (January 2026), and the disclosure explicitly details Cazotto's qualifications and his expanded responsibilities overseeing financial operations, investor relations, strategy, and M&A.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
Item 5.02
Four directors—Andrew Rechtschaffen, Karen Martin, Paul Stoyan, and Harry Brandler—were appointed to the board in connection with the IPO on August 6, 2026, with assignments to specific board committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-10
The filing discloses the appointment of Wesley Batista Filho as Global CEO effective January 2027, alongside the concurrent departure of Gilberto Tomazoni. While both events occur, the principal action announced is Batista Filho's appointment to the top executive role. The filing emphasizes his appointment and career trajectory at JBS, making this the salient event, though the concurrent CEO transition is also material.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 5.02
The disclosure centers on the Board's appointment of Anthony W. Boor as a new Class A director on August 5, 2026. Although the filing also describes his existing role as Executive Vice President of Corporate Development and Strategy and references his retention agreement with compensation details, the principal disclosed action is his election to the Board. This is a material governance event affecting the composition of the registrant's board of directors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-10
Item 5.02
Peter G. Eames was appointed as president and chief executive officer and elected to the Board of Directors, succeeding Daniel A. Baker who retired from the CEO role. Carolyn W. Valentine was also elected to the Board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
The filing discloses a comprehensive executive leadership transition effective August 6, 2026, with the departure of two senior officers (LOKE WENG CHAN and Dr. JIMMY LOKE) and the appointment of five new executives including a new President and CEO (CHAI KOK LEONG), CFO and Board Chairman (GILBERT LOKE), CMO (LOUIS TANG), Chief Strategy Officer (Dr. JIMMY LOKE in a new role), and CTO (ZHENG XIANG). While both departures and appointments occur, the filing's primary focus and structure emphasize the appointment of new leadership across all major executive functions, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-10
Item 5.02
The filing discloses both a departure (Martin Shen's resignation as CEO and Director on August 4, 2026) and an appointment (Jolie Kahn's appointment as CEO and Director effective the same date). While both events occurred, the principal disclosed action centers on the appointment of a new CEO with extensive qualifications in corporate finance, public company leadership, and securities law. The detailed biographical information and forward-looking tone emphasize the appointment as the material event driving the disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
The filing discloses the appointment of Christine Chambers as Chief Financial Officer of MicroVision, Inc., effective August 27, 2026. Item 5.02 explicitly covers this appointment, and the prose centers on her appointment to a principal officer role. While compensatory arrangements are also disclosed, the primary disclosed action is the appointment itself, making exec_appointment the most salient classification. This is material as CFO appointments affect investor assessment of financial leadership and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-10
The filing discloses the appointment of Mr. Diego Cesar Santilli as a Director representing Class A Shares, appointed by the Argentine National State (the Class A shareholder) and acknowledged by the Board on August 10, 2026. This is a clear executive/board appointment event. The appointment is material as it represents a change in board composition at a major oil company where the state is a significant shareholder.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-10
EX-99.2
Innate Pharma appointed Markus Jensen as Chief Medical Officer effective September 1, 2026, succeeding Sonia Quaratino. The appointment is material as it involves a named executive officer role critical to clinical and regulatory execution during a pivotal phase of the company's development.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 5.02
Chris Rogers was appointed to the newly created position of President and Chief Strategy Officer effective July 27, 2026, with expanded strategic and operational oversight across the enterprise, including corporate strategy, business development, M&A, and investor relations. This represents a material senior leadership appointment at the recently IPO'd company (June 2026), expanding his prior Chief Growth Officer role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 5.02
Duolingo appointed Sallie Krawcheck as a Class I director and member of the Audit, Risk and Compliance Committee, effective August 10, 2026. Krawcheck brings extensive financial and operational experience from her prior roles as CFO of Citigroup, CEO of Merrill Lynch, and founder of Ellevest.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 5.02
The Board appointed Angie O'Leary as Executive Vice President and Chief Financial Officer, effective August 6, 2026, following her service as Interim CFO since March 2026. Her compensation package includes a base salary of $425,000, target bonus of 65%, and long-term incentive opportunity of 120%+, along with severance provisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
Item 5.02
The Board appointed Erik J. Bello as Vice President and Chief Accounting Officer, effective August 31, 2026, with responsibility as the Company's principal accounting officer. While the disclosure includes compensation details (base salary of $380,000, sign-on bonus, equity awards), the principal disclosed action is the appointment of a named executive to a material officer role. The compensation is ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
Item 5.02
Timothy Fox was appointed as Chief Financial Officer effective August 11, 2026, with a $399,000 base salary, 80% target bonus, and $1.5 million in equity grants (RSUs and PSUs), bringing 35+ years of finance experience and prior roles at the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
Item 7.01
The filing discloses the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. This is a material executive appointment to a C-suite position with broad responsibility for "all elements of Shoulder Innovations' commercial organization." The press release emphasizes his strategic importance to the company's commercial execution and growth strategy, making this a material governance event affecting investor assessment of leadership and commercial direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-10
Item 5.02
Craig Abrahams was elected as a Class I director and appointed to the Audit Committee, effective August 10, 2026. While the disclosure also mentions his participation in the Non-Employee Director Compensation Policy with RSU grants totaling approximately $585,000 in grant date fair value, the principal disclosed action is the appointment of a new director to the board and a committee. This is a material governance event affecting board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-10
Item 7.01
Robert R. "Rusty" Hutson, Jr. was appointed as Chairman of the Board effective August 5, 2026, assuming the dual role of CEO and Chairman. The filing also notes additional board updates including new Lead Independent Director and Compensation Committee appointments.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-10
Item 5.02
Cary Baetz was appointed as Executive Vice President and Chief Financial Officer effective August 12, 2026, with detailed compensation arrangements including base salary of $500,000 and equity grants totaling approximately $2.625 million. Andrew Judge was also appointed as Senior Vice President of Finance. The appointment of new senior financial leadership is material to investors assessing the company's financial management and capital allocation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
The filing discloses the appointment of George L. Nash, Jr. as a director of Granite Construction Incorporated, effective August 5, 2026. The principal disclosed action is a person taking a role on the Board, with assignment to the Audit/Compliance Committee and Risk Committee. While the disclosure mentions standard director compensation arrangements, the core event is the appointment itself, making this an exec_appointment rather than exec_compensation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
The filing discloses the appointment of Derek Liu as Chief Accounting Officer, effective August 7, 2026, pursuant to an offer letter dated August 6, 2026. The principal disclosed action is a person taking a role (CAO), making this an executive appointment. The disclosure includes his background, compensation terms ($350,000 base salary plus 50% target bonus), and eligibility for long-term incentives, which is material to investors assessing the company's financial leadership.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-07
EX-99.1
The exhibit discloses multiple executive leadership changes effective July 30 and September 30, 2026, including the appointment of Dan Myerson as Chair, Christian Milau as President and CEO, Tamiko Ohta as Senior Vice President Legal and General Counsel, and Paul Ferneyhough's expanded role as EVP Strategy and CFO. While the filing also includes departures (Steven Reid, George Burns, Frank Herbert, Louw Smith), the principal disclosed actions are the appointments and assumption of new roles by named executives, making exec_appointment the best fit. The confidence is moderate (0.75) because the filing bundles multiple concurrent departures and appointments; a strict reading could support exec_departure for Reid and Burns, but the material change report emphasizes the Board and management succession process and the new appointments.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-07
EX-99.1
The exhibit announces the appointment of Ms. Simin Ren as sole Chief Executive Officer and Chairperson of the Board, and Mr. Jie Gao as Vice President of Investment and director, effective August 6–7, 2026. Although Mr. Shaojie Chen's resignation as CEO and director is also disclosed, the principal disclosed action is the appointment of new leadership to fill those roles. The Company states it does not expect material adverse effects, but executive succession at the CEO and board level is material to investors assessing governance and continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-08-07
Item 5.02
Michael D. Ruppert was appointed to the Board of Directors as a Class II director effective August 5, 2026, bringing 25+ years of aerospace and defense financial and strategic experience as ManTech's CFO. Concurrently, director Charles Thomas Burbage retired from the Board effective at the 2026 Annual Meeting. The Board expanded from 9 to 10 directors to accommodate the new appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-07
Item 5.02
Michael George was appointed as Interim Chief Executive Officer effective on the Plan Effective Date, with compensation of $1.5M base salary and a $5M initial equity award with performance conditions, replacing David Rawlinson II. Eight new directors were also appointed to replace eight departing directors, with new board committees and compensation arrangements established.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-08-07
The filing discloses the appointment of Mr. Kunqi Bai as a director of JIADE LIMITED on August 7, 2026, to fill a vacancy created by the resignation of Mr. Xiaohui Li (who was also Joint-Chief Executive Officer). While both a departure and appointment occur, the principal disclosed action is the board's appointment of a new director, making exec_appointment the primary classification. The appointment of a director is material to investors assessing the company's governance and leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
The disclosure centers on the election of Anthony Jabbour as a director effective August 5, 2026, with appointment to the Audit and Risk Committees. While the section also mentions compensation arrangements, the principal action disclosed is the appointment of a new director to the board, making this an exec_appointment event. The appointment of an experienced executive (former CEO of Dun & Bradstreet and Black Knight) to a major insurer's board is material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
The filing discloses the election of Danny Deep, the current president of General Dynamics, to the board of directors effective August 5, 2026. This is a clear executive appointment to a governance role. While Deep already serves as president and receives no additional compensation for the board seat, the principal disclosed action is his appointment as a director, which is material to investors as it reflects board composition changes and governance structure at a major defense contractor.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-08-07
The 6-K discloses the appointment of two new directors effective August 7, 2026: Ms. Hsu Hui Chen as director and co-chief executive officer, and Ms. Lim Fei Fern as independent director and chairperson of the Compensation Committee. While the filing also reports concurrent resignations of three directors (Wu Wai Kong, Mhlengi Prevail Mafu, and Chung Wai Wong), the principal disclosed action is the appointment of the new directors to fill those vacancies, making this an exec_appointment event. The appointment of a co-CEO and multiple committee members is material to investor assessment of governance and leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-07
The filing discloses the Board's unanimous appointment of Ben Wiesenfeld as Chief Compliance Officer effective August 3, 2026, succeeding Scott Betz. While Betz transitions to Chief Operating Officer, the principal disclosed action centers on Wiesenfeld's appointment to the CCO role. As a BDC, compliance officer appointments are material governance events affecting investor assessment of regulatory oversight and internal controls.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-07
The 6-K announces the appointment of three independent directors (Chan Kelvin Zhi Hong, Lee Chee Wai, and Wong Khai Meng) effective August 5, 2026, with detailed biographies and committee assignments. While the filing also discloses three concurrent director resignations, the principal disclosed action is the appointment of new directors to the Board and reconstitution of board committees, which is material to investors' assessment of governance and board composition.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-07
EX-99.1
The news release announces that Joseph Natale will succeed Scott Powers as Chair of the Board of Directors following Sun Life's Annual General Meeting in May 2027. While the release also discloses Powers' retirement, the principal disclosed action is Natale's appointment to the chair role—a material governance event for a major financial services company. The appointment of a new board chair is material to investors assessing leadership and governance quality.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
William List was appointed by the Board as Chief Financial Officer effective September 1, 2026, following Federal Housing Finance Agency non-objection. The disclosure centers on his appointment to this principal financial officer role, his compensation package (base salary of $432,957 and incentive award eligibility), and his background. While the filing also mentions Edward V. Weller's transition to Executive Senior Advisor, the principal disclosed action is List's appointment to the CFO position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-07
Item 5.02
The filing discloses two executive appointments effective August 10, 2026: Andrew C. Wiechmann was appointed to serve as interim principal accounting officer (in addition to his CFO role), and Kristine Johnson was appointed as interim Global Controller. While the filing references a prior departure of the Global Controller and Chief Accounting Officer (disclosed March 31, 2026), the principal action disclosed here is the appointment of successors to fill those roles on an interim basis. The appointments of two officers to key accounting and financial reporting positions are material to investors' assessment of the company's financial controls and reporting infrastructure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-07
Item 5.02
The filing discloses the appointment of Andrey Mushakov to Executive Vice President & Chief Operating Officer on August 6, 2026, a promotion from his prior role as Executive Vice President, Nuclear Operations. While the section also includes compensatory arrangements (RSA Grants), the principal disclosed action centers on the appointment to a material C-suite position. The appointment is material as it represents a significant change in executive leadership and operational responsibility.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
The filing discloses the appointment of two new directors, Peter Martin Rozenauers and Kevin McQuilkin, to Uranium Royalty Corp.'s Board of Directors effective immediately on August 7, 2026. The Board was expanded from six to eight directors to accommodate these appointments. This is a clear executive appointment event under Item 5.02, with material significance given that one appointee (Rozenauers) is affiliated with Orion Sellers, who beneficially own more than 40% of the company's outstanding shares.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
Pinterest appointed Renee Jewell as Chief Accounting Officer effective August 26, 2026. While the disclosure includes compensatory details (base salary of $450,000, sign-on bonus of $225,000, RSU award of $2,550,000, and target annual bonus), the principal disclosed action is the appointment of a named executive officer to a material accounting leadership role. The compensation is ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-07
Item 5.02
The Board of Directors elected Antony F. Spring, currently Chairman and CEO of Macy's, Inc., as a director of Aramark on August 4, 2026. This is a clear executive appointment to the Board, with the filing disclosing his background, roles, and eligibility for director compensation. The appointment of a prominent external executive to the board is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-07
Item 5.02
The filing discloses the appointment of James Sellers as Chief Executive Officer effective December 26, 2026, succeeding retiring CEO Stanley Linville. While the section covers both a departure (Linville's retirement) and an appointment (Sellers' succession), the principal disclosed action centers on the appointment of the new CEO with detailed biographical information, employment agreement terms, and compensation arrangements. The appointment of a new CEO is material to investors' assessment of company leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-07
Item 5.02
The filing discloses the appointment of John Yetimoglu as a director of Biohaven Ltd., effective August 6, 2026, and his appointment to the Nominating and Governance Committee. While the disclosure also includes compensatory details (options with $713,875 grant date fair value and a $57,000 annual retainer), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-06
Item 5.02
Arrow Electronics appointed Deidra C. Merriwether as President and Chief Operating Officer, effective September 8, 2026, with a base salary of $900,000, target incentive awards, and substantial equity grants totaling approximately $9.5 million.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-06
Item 5.02
The Board unanimously appointed Wade M. Jenke as CEO and President, Sui Man Ho as CFO, and Joseph Haughawout as COO, effective August 6, 2026, representing a significant management transition at the principal executive officer and key officer levels.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-06
Item 5.02
Bausch & Lomb appointed four new directors effective August 5, 2026: Thomas J. Appio (CEO of parent company Bausch Health), Robert Chersi, Laurence Paul, M.D., and Barbara Trebbi, at the request of controlling shareholder Bausch Health Companies Inc. The appointments represent a significant governance change and board restructuring.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-08-06
The 6-K furnishes Exhibit 1, a press release titled "BAT Announces Management Board Changes" dated August 6, 2026. While the body of the 6-K itself contains no substantive disclosure, the exhibit index explicitly references a management board changes announcement. Management board changes typically involve executive appointments, departures, or both. Given the title and the materiality of such changes to a major multinational corporation, this disclosure is classified as an executive appointment or departure event. The confidence is slightly moderated because the actual content of the management changes is not reproduced in the body text provided, but the exhibit title is unambiguous.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-06
EX-99.1
The press release announces the appointment of James Bannantine as Co-Chief Executive Officer of Largo Inc., effective immediately. While the release also mentions Daniel Tellechea's retirement from the Co-CEO role, the principal disclosed action is Bannantine's appointment to a named executive officer position. The appointment is material because it represents a significant senior leadership transition at the company's highest level, with Bannantine bringing substantial turnaround and operational expertise relevant to Largo's strategic priorities.
View raw filing on EDGAR →